Published On: Wed, Oct 19th, 2016

Analyst Coverage: Medidata Solutions, Inc. (NASDAQ:MDSO)


Recently stock market analysts have updated their consensus ratings on shares of Medidata Solutions, Inc. (NASDAQ:MDSO).

Most recent broker ratings

07/21/2016 – Medidata Solutions, Inc. was downgraded to “market perform” by analysts at Wells Fargo.

07/21/2016 – Medidata Solutions, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 60 price target on the stock.

04/26/2016 – Medidata Solutions, Inc. was downgraded to “underperform” by analysts at Jefferies. They now have a USD 36 price target on the stock.

04/26/2016 – Leerink Swann began new coverage on Medidata Solutions, Inc. giving the company a “market perform” rating. They now have a USD 47 price target on the stock.

04/22/2016 – Medidata Solutions, Inc. had its “buy” rating reiterated by analysts at Topeka Capital Markets. They now have a USD 51 price target on the stock.

04/22/2016 – Medidata Solutions, Inc. had its “buy” rating reiterated by analysts at Citigroup. They now have a USD 55 price target on the stock.

02/11/2016 – Medidata Solutions, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 41 price target on the stock.

12/08/2015 – Medidata Solutions, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 61 price target on the stock.

10/28/2015 – Medidata Solutions, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 60 price target on the stock.

09/09/2015 – KeyBanc began new coverage on Medidata Solutions, Inc. giving the company a “overweight” rating. They now have a USD 60 price target on the stock.

04/27/2015 – Medidata Solutions, Inc. had its “neutral” rating reiterated by analysts at SunTrust. They now have a USD 58 price target on the stock.

03/09/2015 – Medidata Solutions, Inc. was downgraded to “neutral” by analysts at Zacks. They now have a USD 52.5 price target on the stock.

10/29/2014 – Medidata Solutions, Inc. had its “overweight” rating reiterated by analysts at JP Morgan. They now have a USD 50 price target on the stock.

10/29/2014 – Medidata Solutions, Inc. had its “outperform” rating reiterated by analysts at Credit Suisse. They now have a USD 49 price target on the stock.

09/04/2014 – Morgan Stanley began new coverage on Medidata Solutions, Inc. giving the company a “overweight” rating. They now have a USD 56 price target on the stock.

Medidata Solutions, Inc. has a 50 day moving average of 54.66 and a 200 day moving average of 48.81. The stock’s market capitalization is 2.78B, it has a 52-week low of 30.22 and a 52-week high of 57.21.

The share price of the company (NASDAQ:MDSO) was up +0.93%, with a high of 50.64during the day and the volume of Medidata Solutions, Inc. shares traded was 480763.

Medidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development. Its Planning Cloud provides capabilities for study design and planning, enabling customers to make use of resources through planning at the start of trial design and protocol development. Specific functionality supports visibility into the impact of protocol elements on resource and trial endpoints; comparisons to specific industry benchmarks, and analytics to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Data Capture Cloud is Medidata’s electronic data capture (EDC) and its management system solution is Medidata Rave.